Veracyte Target Price

Where could VCYT trade next? Consensus target price: $57.

Get informed when a big investor buys or sells

+ Follow

Share Price

$45.43

Average Target Price

$57.45

26.5% upside

11 analysts in the last 4 months

High: $69 | Low: $44

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-09	UBS	$65	43.1% upside
2026-08-04	Morgan Stanley	$44	3.1% downside
2026-08-04	Stephens	$55	21.1% upside
2026-08-04	Piper Sandler	$54	18.9% upside
2026-08-03	Canaccord GenuityKyle Mikson	$50	10.1% upside
2026-07-31	NeedhamMike Matson	$69	51.9% upside
2026-07-15	Piper SandlerDavid Westenberg	$66	45.3% upside
2026-07-14	Canaccord Genuity	$60	32.1% upside
2026-07-09	Morgan Stanley	$47	3.5% upside
2026-06-29	GuggenheimSubbu Nambi	$65	43.1% upside
2026-06-01	NeedhamMike Matson	$57	25.5% upside
2026-05-06	UBS	$52	14.5% upside
2026-05-06	Canaccord GenuityKyle Mikson	$42	7.6% downside
2026-03-05	Morgan StanleyKallum Titchmarsh	$37	18.6% downside
2026-01-05	GuggenheimSubbu Nambi	$50	10.1% upside
2025-12-01	Morgan Stanley	$48	5.7% upside
2025-11-05	UBSLu Li	$48	5.7% upside
2025-11-05	Canaccord GenuityKyle Mikson	$43	5.3% downside
2025-10-20	Canaccord GenuityKyle Mikson	$40	12% downside
2025-08-08	Morgan StanleyTejas Savant	$28	38.4% downside
2024-11-07	NeedhamMike Matson	$44	3.1% downside
2024-08-12	Morgan StanleyTejas Savant	$26	42.8% downside
2022-05-04	Morgan Stanley	$23	49.4% downside
2022-05-04	Needham	$26	42.8% downside

Veracyte (VCYT) FAQ

Veracyte (VCYT) currently reports a target price of $57. Use the charts on this page to explore Veracyte's target price history and peer comparisons.

Analysts' average 12-month price target for Veracyte is $57, about 26.5% upside from the current share price of $45.43. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $57, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Veracyte, and consider following VCYT for alerts when major investors trade the stock.

Veracyte is classified in the Healthcare sector. On target price, it currently shows $57. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VCYT with unrelated industries.